MetaVia Inc. (MTVA)
NASDAQ: MTVA · Real-Time Price · USD
3.110
0.00 (0.00%)
At close: Jan 16, 2026, 4:00 PM EST
3.040
-0.070 (-2.25%)
Pre-market: Jan 20, 2026, 7:00 AM EST
MetaVia Market Cap
MetaVia has a market cap or net worth of $9.98 million as of January 20, 2026. Its market cap has decreased by -42.95% in one year.
Market Cap
9.98M
Enterprise Value
-4.23M
1-Year Change
-42.95%
Ranking
Category
Stock Price
$3.11
Market Cap Chart
Since December 31, 2019, MetaVia's market cap has decreased from $104.41B to $9.98M, a decrease of -99.99%. That is a compound annual growth rate of -78.35%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 9.98M | -46.17% |
| Dec 31, 2025 | 18.54M | 5.97% |
| Dec 31, 2024 | 17.49M | -2.47% |
| Dec 29, 2023 | 17.93M | 31.75% |
| Dec 30, 2022 | 13.61M | -58.04% |
| Dec 31, 2021 | 32.44M | -62.38% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 929.76B |
| Johnson & Johnson | 526.82B |
| AbbVie | 378.84B |
| UnitedHealth Group | 299.85B |
| AstraZeneca | 291.69B |
| Novartis AG | 276.38B |
| Merck & Co. | 270.12B |
| Novo Nordisk | 268.23B |